A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2002
12/18/2002	EP1266661A1 Anticancer compositions
12/18/2002	EP1266660A1 Heme oxygenase-1 inducers or induction enhancers
12/18/2002	EP1266654A1 Stabilised amlodipine maleate formulations
12/18/2002	EP1266224A1 Modulation of histone deacetylase
12/18/2002	EP1266208A1 Method of screening compounds for biological activity
12/18/2002	EP1266039A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265927A1 Crystal
12/18/2002	EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265918A1 Human immune response proteins
12/18/2002	EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002	EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
12/18/2002	EP1265907A2 Novel aryl fructose-1,6-bisphosphatase inhibitors
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002	EP1265895A1 4-oxo-1,4-dihydro 1,8]naphthyridine-3-carboxamides as antiviral agents
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265881A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
12/18/2002	EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
12/18/2002	EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
12/18/2002	EP1265871A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure
12/18/2002	EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002	EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265857A1 Sulfonamide derivatives
12/18/2002	EP1265855A1 Novel cd23 inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265838A1 Novel fatty acid analogous
12/18/2002	EP1265637A2 Compositions and methods for affecting osteogenesis
12/18/2002	EP1265636A2 Improved treatment of neovascularization
12/18/2002	EP1265629A1 Use of growth hormone in low dose
12/18/2002	EP1265628A1 Use of human not1 and not1a orphan receptors
12/18/2002	EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002	EP1265621A2 Use of cdp-choline for the prophylactic treatment of cerebral ischemia
12/18/2002	EP1265615A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis
12/18/2002	EP1265611A2 Farnesyl protein transferase inhibitor combinations with taxane compounds
12/18/2002	EP1265607A2 METHOD FOR THE TREATMENT OF RENAL DYSFUNCTION WITH sPLA 2 INHIBITORS
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1149096B1 Tricyclic pyridine n-oxides vasopressin agonists
12/18/2002	EP1119564B1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists
12/18/2002	EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP1017275A4 Polyamine treatment of neurological disorders
12/18/2002	EP0973801B1 GnRH ANTAGONISTS
12/18/2002	EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/18/2002	EP0938331B1 Therapeutic uses of bpi protein products in cystic fibrosis patients
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0930889B1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
12/18/2002	EP0892811B1 Peptides with antiproliferative properties
12/18/2002	EP0891344B1 Alpha-1 adrenergic receptor antagonists
12/18/2002	EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002	EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii)
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0871473B1 Use of il-10 for wound healing with reduced scarring
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0859607B1 Guanidino protease inhibitors
12/18/2002	EP0832085B1 Phosphinic acid derivatives with metallopeptidase inhibitory activity
12/18/2002	EP0788792B1 Matrix type patch preparation
12/18/2002	EP0646019B9 Biotin-DOTA conjugates and their use in pretargeting methods
12/18/2002	CN1385425A Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1,4-dihydro-2H-3,1-benzoxazine-2-ketone
12/18/2002	CN1385198A Medicine for treating ADHD (Attentional Deficit Hyperactivity Disorder)
12/18/2002	CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002	CN1096461C Purine derivatives and their use as anti-coagulants
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CN1096448C Farnesyl transferase inhibitors, its preparation and medicine composition thereof
12/18/2002	CN1096277C Perfume liquid extract capable of improving indoor air and regulating qi and blood
12/17/2002	US6495686 Therapy for psychological disorders
12/17/2002	US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine
12/17/2002	US6495677 Nucleoside compounds
12/17/2002	US6495663 Method and composition for enhancing transport across biological membranes
12/17/2002	US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine
12/17/2002	US6495604 Cycloalkene derivatives, process for producing the same, and use
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495587 Tricyclic indole-2-carboxylic acid compound used as NMDA receptor antagonist
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495578 Sulfonamide derivatives having oxadiazole rings
12/17/2002	US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/17/2002	US6495573 Non-systemic control of parasites
12/17/2002	US6495568 Treatment of tissue ulceration, wound repair and skin diseases
12/17/2002	US6495566 Potent antagonists at the strychnine insensitive glycine binding site associated with the n-methylaspartic acid receptor complex
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002	US6495561 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
12/17/2002	US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis
12/17/2002	US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/17/2002	US6495556 Treating leukemia and lymphoma, sunburn and skin cancer

1 ... 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 ... 1564